246 related articles for article (PubMed ID: 29408561)
1. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.
Donlon CM; LeBoff MS; Chou SH; Cook NR; Copeland T; Buring JE; Bubes V; Kotler G; Manson JE
Contemp Clin Trials; 2018 Apr; 67():56-67. PubMed ID: 29408561
[TBL] [Abstract][Full Text] [Related]
2. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).
LeBoff MS; Yue AY; Copeland T; Cook NR; Buring JE; Manson JE
Contemp Clin Trials; 2015 Mar; 41():259-68. PubMed ID: 25623291
[TBL] [Abstract][Full Text] [Related]
3. Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL).
Chou SH; Murata EM; Yu C; Danik J; Kotler G; Cook NR; Bubes V; Mora S; Chandler PD; Tobias DK; Copeland T; Buring JE; Manson JE; LeBoff MS
J Clin Endocrinol Metab; 2021 Apr; 106(5):1377-1388. PubMed ID: 33513226
[TBL] [Abstract][Full Text] [Related]
4. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
[TBL] [Abstract][Full Text] [Related]
5. VITamin D and OmegA-3 TriaL (VITAL) bone health ancillary study: clinical factors associated with trabecular bone score in women and men.
Goldman AL; Donlon CM; Cook NR; Manson JE; Buring JE; Copeland T; Yu CY; LeBoff MS
Osteoporos Int; 2018 Nov; 29(11):2505-2515. PubMed ID: 30022253
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
[TBL] [Abstract][Full Text] [Related]
7. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
Okereke OI; Reynolds CF; Mischoulon D; Chang G; Cook NR; Copeland T; Friedenberg G; Buring JE; Manson JE
Contemp Clin Trials; 2018 May; 68():133-145. PubMed ID: 29526608
[TBL] [Abstract][Full Text] [Related]
8. Methods and procedures for: A randomized double-blind study investigating dose-dependent longitudinal effects of vitamin D supplementation on bone health.
Burt LA; Gaudet S; Kan M; Rose MS; Billington EO; Boyd SK; Hanley DA
Contemp Clin Trials; 2018 Apr; 67():68-73. PubMed ID: 29471124
[TBL] [Abstract][Full Text] [Related]
9. Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL).
LeBoff MS; Chou SH; Murata EM; Donlon CM; Cook NR; Mora S; Lee IM; Kotler G; Bubes V; Buring JE; Manson JE
J Bone Miner Res; 2020 May; 35(5):883-893. PubMed ID: 31923341
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment.
Luttmann-Gibson H; Mora S; Camargo CA; Cook NR; Demler OV; Ghoshal A; Wohlgemuth J; Kulkarni K; Larsen J; Prentice J; Cobble M; Bubes V; Li C; Friedenberg G; Lee IM; Buring JE; Manson JE
Contemp Clin Trials; 2019 Dec; 87():105854. PubMed ID: 31669447
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE;
Circ Res; 2020 Jan; 126(1):112-128. PubMed ID: 31895658
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose cholecalciferol (vitamin D
Rovner AJ; Stallings VA; Rutstein R; Schall JI; Leonard MB; Zemel BS
Osteoporos Int; 2017 Jan; 28(1):201-209. PubMed ID: 27837268
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
[TBL] [Abstract][Full Text] [Related]
14. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population.
LeBoff MS; Murata EM; Cook NR; Cawthon P; Chou SH; Kotler G; Bubes V; Buring JE; Manson JE
J Clin Endocrinol Metab; 2020 Sep; 105(9):2929-38. PubMed ID: 32492153
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
Hansen KE; Johnson RE; Chambers KR; Johnson MG; Lemon CC; Vo TN; Marvdashti S
JAMA Intern Med; 2015 Oct; 175(10):1612-21. PubMed ID: 26237520
[TBL] [Abstract][Full Text] [Related]
16. Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial.
Burt LA; Billington EO; Rose MS; Raymond DA; Hanley DA; Boyd SK
JAMA; 2019 Aug; 322(8):736-745. PubMed ID: 31454046
[TBL] [Abstract][Full Text] [Related]
17. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
[TBL] [Abstract][Full Text] [Related]
18. Update on the Vitamin D and OmegA-3 trial (VITAL).
Pradhan AD; Manson JE
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):252-6. PubMed ID: 25864623
[TBL] [Abstract][Full Text] [Related]
19. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
[TBL] [Abstract][Full Text] [Related]
20. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
Bischoff-Ferrari HA; Vellas B; Rizzoli R; Kressig RW; da Silva JAP; Blauth M; Felson DT; McCloskey EV; Watzl B; Hofbauer LC; Felsenberg D; Willett WC; Dawson-Hughes B; Manson JE; Siebert U; Theiler R; Staehelin HB; de Godoi Rezende Costa Molino C; Chocano-Bedoya PO; Abderhalden LA; Egli A; Kanis JA; Orav EJ;
JAMA; 2020 Nov; 324(18):1855-1868. PubMed ID: 33170239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
